Form 8-K PharMerica CORP For: Nov 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Pharmerica (PMC) Tops Q3 EPS by 5c; Boosts FY14 Outlook
November 6, 2014 8:23 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $470.2 million versus the consensus estimate of $439.63 million.
Pharmerica sees FY2014 EPS of $1.62-$1.64, versus prior guidance of $1.58-$1.62 and the consensus of $1.59. Pharmerica sees... More
